{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:05:37Z","timestamp":1779843937635,"version":"3.53.1"},"reference-count":46,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"21","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurosurg Case Lessons"],"published-print":{"date-parts":[[2026,5,25]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>18<\/jats:sup>\n                      F]-Fluciclovine PET is increasingly used for visualizing malignant gliomas and delineating tumor infiltration. More recently, its utility has been reported in differentiating tumor recurrence from radiation necrosis (RN). However, the behavior of [\n                      <jats:sup>18<\/jats:sup>\n                      F]-fluciclovine PET in newly identified intracranial contrast-enhancing lesions, particularly at initial presentation, remains unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>\n                      A 57-year-old man developed a new ring-enhancing lesion in the left frontal lobe 4.5 years after proton therapy for ethmoid sinus carcinoma. MRI demonstrated progressive enlargement of the lesion over 4 months. [\n                      <jats:sup>18<\/jats:sup>\n                      F]-Fluciclovine PET showed moderate uptake (maximum standardized uptake value [SUV\n                      <jats:sub\/>\n                      ] 2.96) with a markedly elevated tumor-to-background ratio (TBR 22.77), raising concern for a high-grade glioma. Resection was performed; however, histopathological and molecular analyses confirmed RN.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>\n                      This rare case highlights an important diagnostic pitfall in which [\n                      <jats:sup>18<\/jats:sup>\n                      F]-fluciclovine PET demonstrates markedly elevated TBR despite only moderate SUV in RN. Discordant findings between SUV and TBR should be interpreted cautiously, as they may not always indicate active tumor. Careful integration of clinical course, longitudinal imaging findings, and treatment history is important for appropriate clinical decision-making.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/thejns.org\/doi\/10.3171\/CASE26222\">https:\/\/thejns.org\/doi\/10.3171\/CASE26222<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case26222","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:52:38Z","timestamp":1779288758000},"source":"Crossref","is-referenced-by-count":0,"title":["Unexpected [18F]-fluciclovine hyperuptake in radiation necrosis after proton therapy: illustrative case"],"prefix":"10.3171","volume":"11","author":[{"given":"Kazuaki","family":"Kamata","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-5306","authenticated-orcid":true,"given":"Seisuke","family":"Tanigawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-180X","authenticated-orcid":true,"given":"Takanari","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-1631","authenticated-orcid":true,"given":"Ichita","family":"Taniyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Japanese Red Cross Kyoto Daini Hospital, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0853-0615","authenticated-orcid":true,"given":"Takumi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Aibe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3059-7721","authenticated-orcid":true,"given":"Sachimi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto Prefectural University of Medicine, Kyoto"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"5","key":"bib1","series-title":"AJNR Am J Neuroradiol","first-page":"944","article-title":"Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis","volume":"34","author":"Nihashi","year":"2013","unstructured":"Nihashi TDahabreh IJTerasawa T.Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. AJNR Am J Neuroradiol. 2013;34(5):944-950. doi:10.3174\/ajnr.A3324"},{"issue":"6","key":"bib2","series-title":"Eur J Nucl Med Mol Imaging","first-page":"1353","article-title":"18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors","volume":"47","author":"Michaud","year":"2020","unstructured":"Michaud LBeattie BJAkhurst T18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors. Eur J Nucl Med Mol Imaging. 2020;47(6):1353-1367. doi:10.1007\/s00259-019-04433-1"},{"issue":"4","key":"bib3","series-title":"Semin Cancer Biol","first-page":"254","article-title":"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?","volume":"15","author":"Fuchs","year":"2005","unstructured":"Fuchs BCBode BP.Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 2005;15(4):254-266. doi:10.1016\/j.semcancer.2005.04.005"},{"issue":"1","key":"bib4","series-title":"Nucl Med Biol","first-page":"109","article-title":"Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells","volume":"39","author":"Oka","year":"2012","unstructured":"Oka SOkudaira HYoshida YSchuster DMGoodman MMShirakami Y.Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol. 2012;39(1):109-119. doi:10.1016\/j.nucmedbio.2011.06.008"},{"issue":"3","key":"bib5","series-title":"Mol Imaging Biol","first-page":"322","article-title":"Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with l-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-d-glucose","volume":"16","author":"Oka","year":"2014","unstructured":"Oka SOkudaira HOno MDifferences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with l-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-d-glucose. Mol Imaging Biol. 2014;16(3):322-329. doi:10.1007\/s11307-013-0693-0"},{"key":"bib6","series-title":"Brain Res","first-page":"24","article-title":"Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines","volume":"1535","author":"Ono","year":"2013","unstructured":"Ono MOka SOkudaira HComparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines. Brain Res. 2013;1535:24-37. doi:10.1016\/j.brainres.2013.08.037"},{"issue":"2","key":"bib7","series-title":"Asia Ocean J Nucl Med Biol","first-page":"85","article-title":"Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: a comparative study with l-methyl-11C-methionine PET imaging","volume":"5","author":"Tsuyuguchi","year":"2017","unstructured":"Tsuyuguchi NTerakawa YUda TNakajo KKanemura Y.Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: a comparative study with l-methyl-11C-methionine PET imaging. Asia Ocean J Nucl Med Biol. 2017;5(2):85-94. doi:10.22038\/aojnmb.2017.8843"},{"issue":"6","key":"bib8","series-title":"PLoS One","first-page":"e0157139","article-title":"Study of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers","volume":"11","author":"Papin-Michault","year":"2016","unstructured":"Papin-Michault CBonnetaud CDufour MStudy of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers. PLoS One. 2016;11(6):e0157139. doi:10.1371\/journal.pone.0157139"},{"issue":"2","key":"bib9","series-title":"J Neurooncol","first-page":"423","article-title":"The distribution of vascular endothelial growth factor\u2014producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles","volume":"105","author":"Nonoguchi","year":"2011","unstructured":"Nonoguchi NMiyatake SIFukumoto MThe distribution of vascular endothelial growth factor\u2014producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol. 2011;105(2):423-431. doi:10.1007\/s11060-011-0610-9"},{"issue":"4","key":"bib10","series-title":"J Radiat Res","first-page":"803","article-title":"Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis","volume":"55","author":"Yoritsune","year":"2014","unstructured":"Yoritsune EFuruse MKuwabara HInflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis. J Radiat Res. 2014;55(4):803-811. doi:10.1093\/jrr\/rru017"},{"key":"bib11","series-title":"Neurochem Int","first-page":"199","article-title":"X-ray irradiation induces disruption of the blood\u2013brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain","volume":"119","author":"Yoshida","year":"2018","unstructured":"Yoshida YSejimo YKurachi MIshizaki YNakano TTakahashi A.X-ray irradiation induces disruption of the blood\u2013brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain. Neurochem Int. 2018;119:199-206. doi:10.1016\/j.neuint.2018.03.002"},{"issue":"1","key":"bib12","series-title":"EJNMMI Res","first-page":"148","article-title":"[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis","volume":"10","author":"Parent","year":"2020","unstructured":"Parent EEPatel DNye JA[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis. EJNMMI Res. 2020;10(1):148. doi:10.1186\/s13550-020-00739-6"},{"issue":"6","key":"bib13","series-title":"J Nucl Med","first-page":"852","article-title":"Distinguishing progression from pseudoprogression in glioblastoma using 18F-fluciclovine PET","volume":"64","author":"Nabavizadeh","year":"2023","unstructured":"Nabavizadeh ABagley SJDoot RKDistinguishing progression from pseudoprogression in glioblastoma using 18F-fluciclovine PET. J Nucl Med. 2023;64(6):852-858. doi:10.2967\/jnumed.122.264812"},{"issue":"3","key":"bib14","series-title":"J Neurooncol","first-page":"647","article-title":"18F-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study","volume":"163","author":"Tom","year":"2023","unstructured":"Tom MCDiFilippo FPJones SE18F-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study. J Neurooncol. 2023;163(3):647-655. doi:10.1007\/s11060-023-04377-5"},{"issue":"1","key":"bib15","series-title":"Neurooncol Adv","first-page":"vdae053","article-title":"Preoperative growth dynamics of untreated glioblastoma: description of an exponential growth type, correlating factors, and association with postoperative survival","volume":"6","author":"Feucht","year":"2024","unstructured":"Feucht DHaas PSkardelly MPreoperative growth dynamics of untreated glioblastoma: description of an exponential growth type, correlating factors, and association with postoperative survival. Neurooncol Adv. 2024;6(1):vdae053. doi:10.1093\/noajnl\/vdae053"},{"issue":"10","key":"bib16","series-title":"Neuro Oncol","first-page":"1402","article-title":"Growth dynamics of untreated glioblastomas in vivo","volume":"17","author":"Stensj\u00f8en","year":"2015","unstructured":"Stensj\u00f8en ALSolheim OKvistad KAH\u00e5berg AKSalvesen \u00d8Berntsen EM.Growth dynamics of untreated glioblastomas in vivo. Neuro Oncol. 2015;17(10):1402-1411. doi:10.1093\/neuonc\/nov029"},{"issue":"3","key":"bib17","series-title":"Hum Pathol","first-page":"272","article-title":"Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions?","volume":"37","author":"Tihan","year":"2006","unstructured":"Tihan TBarletta JParney ILamborn KSneed PKChang S.Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol. 2006;37(3):272-282. doi:10.1016\/j.humpath.2005.11.010"},{"issue":"5","key":"bib18","series-title":"Lancet Oncol","first-page":"453","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","unstructured":"Brandsma DStalpers LTaal WSminia Pvan den Bent MJ.Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453-461. doi:10.1016\/S1470-2045(08)70125-6"},{"issue":"5","key":"bib19","series-title":"Neurosurgery","first-page":"898","article-title":"Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study","volume":"63","author":"Dequesada","year":"2008","unstructured":"Dequesada IMQuisling RGYachnis AFriedman WA.Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery. 2008;63(5):898-904. doi:10.1227\/01.NEU.0000333263.31870.31"},{"key":"bib20","series-title":"World Neurosurg","first-page":"187","article-title":"5-Aminolevulinic acid false positives in cerebral neuro-oncology: not all that is fluorescent is tumor. A case-based update and literature review","volume":"137","author":"La Rocca","year":"2020","unstructured":"La Rocca GSabatino GMenna G5-Aminolevulinic acid false positives in cerebral neuro-oncology: not all that is fluorescent is tumor. A case-based update and literature review. World Neurosurg. 2020;137:187-193. doi:10.1016\/j.wneu.2020.01.238"},{"issue":"22","key":"bib21","series-title":"Phys Med Biol","first-page":"R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","unstructured":"Paganetti H.Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419-R472. doi:10.1088\/0031-9155\/59\/22\/R419"},{"issue":"11","key":"bib22","series-title":"Acta Oncol","first-page":"1387","article-title":"Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo","volume":"56","author":"S\u00f8rensen","year":"2017","unstructured":"S\u00f8rensen BSBassler NNielsen SRelative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo. Acta Oncol. 2017;56(11):1387-1391. doi:10.1080\/0284186X.2017.1351621"},{"issue":"2","key":"bib23","series-title":"Adv Radiat Oncol","first-page":"101128","article-title":"Linear energy transfer and relative biological effectiveness investigation of various structures for a cohort of proton patients with brain tumors","volume":"8","author":"Vaniqui","year":"2022","unstructured":"Vaniqui AVaassen FDi Perri DDLinear energy transfer and relative biological effectiveness investigation of various structures for a cohort of proton patients with brain tumors. Adv Radiat Oncol. 2022;8(2):101128. doi:10.1016\/j.adro.2022.101128"},{"issue":"5","key":"bib1","series-title":"AJNR Am J Neuroradiol","first-page":"944","article-title":"Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis","volume":"34","author":"Nihashi","year":"2013","unstructured":"Nihashi TDahabreh IJTerasawa T.Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. AJNR Am J Neuroradiol. 2013;34(5):944-950. doi:10.3174\/ajnr.A3324"},{"issue":"6","key":"bib2","series-title":"Eur J Nucl Med Mol Imaging","first-page":"1353","article-title":"18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors","volume":"47","author":"Michaud","year":"2020","unstructured":"Michaud LBeattie BJAkhurst T18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors. Eur J Nucl Med Mol Imaging. 2020;47(6):1353-1367. doi:10.1007\/s00259-019-04433-1"},{"issue":"4","key":"bib3","series-title":"Semin Cancer Biol","first-page":"254","article-title":"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?","volume":"15","author":"Fuchs","year":"2005","unstructured":"Fuchs BCBode BP.Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 2005;15(4):254-266. doi:10.1016\/j.semcancer.2005.04.005"},{"issue":"1","key":"bib4","series-title":"Nucl Med Biol","first-page":"109","article-title":"Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells","volume":"39","author":"Oka","year":"2012","unstructured":"Oka SOkudaira HYoshida YSchuster DMGoodman MMShirakami Y.Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol. 2012;39(1):109-119. doi:10.1016\/j.nucmedbio.2011.06.008"},{"issue":"3","key":"bib5","series-title":"Mol Imaging Biol","first-page":"322","article-title":"Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with l-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-d-glucose","volume":"16","author":"Oka","year":"2014","unstructured":"Oka SOkudaira HOno MDifferences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with l-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-d-glucose. Mol Imaging Biol. 2014;16(3):322-329. doi:10.1007\/s11307-013-0693-0"},{"key":"bib6","series-title":"Brain Res","first-page":"24","article-title":"Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines","volume":"1535","author":"Ono","year":"2013","unstructured":"Ono MOka SOkudaira HComparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines. Brain Res. 2013;1535:24-37. doi:10.1016\/j.brainres.2013.08.037"},{"issue":"2","key":"bib7","series-title":"Asia Ocean J Nucl Med Biol","first-page":"85","article-title":"Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: a comparative study with l-methyl-11C-methionine PET imaging","volume":"5","author":"Tsuyuguchi","year":"2017","unstructured":"Tsuyuguchi NTerakawa YUda TNakajo KKanemura Y.Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: a comparative study with l-methyl-11C-methionine PET imaging. Asia Ocean J Nucl Med Biol. 2017;5(2):85-94. doi:10.22038\/aojnmb.2017.8843"},{"issue":"6","key":"bib8","series-title":"PLoS One","first-page":"e0157139","article-title":"Study of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers","volume":"11","author":"Papin-Michault","year":"2016","unstructured":"Papin-Michault CBonnetaud CDufour MStudy of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers. PLoS One. 2016;11(6):e0157139. doi:10.1371\/journal.pone.0157139"},{"issue":"2","key":"bib9","series-title":"J Neurooncol","first-page":"423","article-title":"The distribution of vascular endothelial growth factor\u2014producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles","volume":"105","author":"Nonoguchi","year":"2011","unstructured":"Nonoguchi NMiyatake SIFukumoto MThe distribution of vascular endothelial growth factor\u2014producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol. 2011;105(2):423-431. doi:10.1007\/s11060-011-0610-9"},{"issue":"4","key":"bib10","series-title":"J Radiat Res","first-page":"803","article-title":"Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis","volume":"55","author":"Yoritsune","year":"2014","unstructured":"Yoritsune EFuruse MKuwabara HInflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis. J Radiat Res. 2014;55(4):803-811. doi:10.1093\/jrr\/rru017"},{"key":"bib11","series-title":"Neurochem Int","first-page":"199","article-title":"X-ray irradiation induces disruption of the blood\u2013brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain","volume":"119","author":"Yoshida","year":"2018","unstructured":"Yoshida YSejimo YKurachi MIshizaki YNakano TTakahashi A.X-ray irradiation induces disruption of the blood\u2013brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain. Neurochem Int. 2018;119:199-206. doi:10.1016\/j.neuint.2018.03.002"},{"issue":"1","key":"bib12","series-title":"EJNMMI Res","first-page":"148","article-title":"[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis","volume":"10","author":"Parent","year":"2020","unstructured":"Parent EEPatel DNye JA[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis. EJNMMI Res. 2020;10(1):148. doi:10.1186\/s13550-020-00739-6"},{"issue":"6","key":"bib13","series-title":"J Nucl Med","first-page":"852","article-title":"Distinguishing progression from pseudoprogression in glioblastoma using 18F-fluciclovine PET","volume":"64","author":"Nabavizadeh","year":"2023","unstructured":"Nabavizadeh ABagley SJDoot RKDistinguishing progression from pseudoprogression in glioblastoma using 18F-fluciclovine PET. J Nucl Med. 2023;64(6):852-858. doi:10.2967\/jnumed.122.264812"},{"issue":"3","key":"bib14","series-title":"J Neurooncol","first-page":"647","article-title":"18F-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study","volume":"163","author":"Tom","year":"2023","unstructured":"Tom MCDiFilippo FPJones SE18F-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study. J Neurooncol. 2023;163(3):647-655. doi:10.1007\/s11060-023-04377-5"},{"issue":"1","key":"bib15","series-title":"Neurooncol Adv","first-page":"vdae053","article-title":"Preoperative growth dynamics of untreated glioblastoma: description of an exponential growth type, correlating factors, and association with postoperative survival","volume":"6","author":"Feucht","year":"2024","unstructured":"Feucht DHaas PSkardelly MPreoperative growth dynamics of untreated glioblastoma: description of an exponential growth type, correlating factors, and association with postoperative survival. Neurooncol Adv. 2024;6(1):vdae053. doi:10.1093\/noajnl\/vdae053"},{"issue":"10","key":"bib16","series-title":"Neuro Oncol","first-page":"1402","article-title":"Growth dynamics of untreated glioblastomas in vivo","volume":"17","author":"Stensj\u00f8en","year":"2015","unstructured":"Stensj\u00f8en ALSolheim OKvistad KAH\u00e5berg AKSalvesen \u00d8Berntsen EM.Growth dynamics of untreated glioblastomas in vivo. Neuro Oncol. 2015;17(10):1402-1411. doi:10.1093\/neuonc\/nov029"},{"issue":"3","key":"bib17","series-title":"Hum Pathol","first-page":"272","article-title":"Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions?","volume":"37","author":"Tihan","year":"2006","unstructured":"Tihan TBarletta JParney ILamborn KSneed PKChang S.Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol. 2006;37(3):272-282. doi:10.1016\/j.humpath.2005.11.010"},{"issue":"5","key":"bib18","series-title":"Lancet Oncol","first-page":"453","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","unstructured":"Brandsma DStalpers LTaal WSminia Pvan den Bent MJ.Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453-461. doi:10.1016\/S1470-2045(08)70125-6"},{"issue":"5","key":"bib19","series-title":"Neurosurgery","first-page":"898","article-title":"Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study","volume":"63","author":"Dequesada","year":"2008","unstructured":"Dequesada IMQuisling RGYachnis AFriedman WA.Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery. 2008;63(5):898-904. doi:10.1227\/01.NEU.0000333263.31870.31"},{"key":"bib20","series-title":"World Neurosurg","first-page":"187","article-title":"5-Aminolevulinic acid false positives in cerebral neuro-oncology: not all that is fluorescent is tumor. A case-based update and literature review","volume":"137","author":"La Rocca","year":"2020","unstructured":"La Rocca GSabatino GMenna G5-Aminolevulinic acid false positives in cerebral neuro-oncology: not all that is fluorescent is tumor. A case-based update and literature review. World Neurosurg. 2020;137:187-193. doi:10.1016\/j.wneu.2020.01.238"},{"issue":"22","key":"bib21","series-title":"Phys Med Biol","first-page":"R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","unstructured":"Paganetti H.Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419-R472. doi:10.1088\/0031-9155\/59\/22\/R419"},{"issue":"11","key":"bib22","series-title":"Acta Oncol","first-page":"1387","article-title":"Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo","volume":"56","author":"S\u00f8rensen","year":"2017","unstructured":"S\u00f8rensen BSBassler NNielsen SRelative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo. Acta Oncol. 2017;56(11):1387-1391. doi:10.1080\/0284186X.2017.1351621"},{"issue":"2","key":"bib23","series-title":"Adv Radiat Oncol","first-page":"101128","article-title":"Linear energy transfer and relative biological effectiveness investigation of various structures for a cohort of proton patients with brain tumors","volume":"8","author":"Vaniqui","year":"2022","unstructured":"Vaniqui AVaassen FDi Perri DDLinear energy transfer and relative biological effectiveness investigation of various structures for a cohort of proton patients with brain tumors. Adv Radiat Oncol. 2022;8(2):101128. doi:10.1016\/j.adro.2022.101128"}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/11\/21\/article-CASE26222.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/11\/21\/article-CASE26222.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/11\/21\/article-CASE26222.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:39:38Z","timestamp":1779842378000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/11\/21\/article-CASE26222.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":46,"journal-issue":{"issue":"21"},"URL":"https:\/\/doi.org\/10.3171\/case26222","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}